10x Genomics launched Atera, a new in situ spatial biology platform designed to deliver whole-transcriptome spatial analysis with single-cell sensitivity at scale. The company said Atera can support large-scale studies across fresh-frozen and FFPE tissue, addressing historic tradeoffs among scale, sensitivity, and gene selection in spatial assays. The platform launch includes early access data analyzed at Carl June’s lab and other research institutions, and it is set to be showcased at the AACR Annual Meeting 2026. (A platform like this measures gene expression directly in tissue coordinates rather than dissociated cells.) For translational researchers, the message is that spatial transcriptomics can now move toward more comprehensive, whole-transcriptome mapping without sacrificing cellular resolution—potentially tightening the loop between discovery findings and tissue-context validation.